Brief: Glenmark Pharmaceuticals Says Partner Elite Pharmaceuticals Got USFDA Nod For Methadone Hydrochloride Tablets
07/08/2018 09:23
Aug 7 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS :
* PARTNER ELITE PHARMACEUTICALS RECEIVED APPROVAL FROM USFDA
FOR
METHADONE HYDROCHLORIDE 5 MG AND 10 MG TABLETS
* METHADONE IS INDICATED FOR MANAGEMENT OF PAIN SEVERE
ENOUGH TO
REQUIRE DAILY, AROUND--CLOCK LONG-TERM OPIOID TREATMENT
Source text: http://bit.ly/2AOGqT4
Further company coverage: GLEN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elite Pharmaceuticals
See all newsBrief: Elite Pharmaceuticals Receives Approval From FDA On May 16, For A Generic Version Of Methotrexate Sodium 2.5 Mg Tablets
Brief: Lannett Enters Into Distribution Agreement For Dantrolene Capsules
Brief: Lannett Enters Into Distribution Agreement For Generic Adderall
Brief: Elite Pharmaceuticals Gets FDA Approval For Generic Version Of Allergan's Pain Treatment Tablets
Brief: Elite Pharmaceuticals Files ANDA For Codeine And Acetaminophen Combo